Knipp U, Birkholz S, Kaup W, Opferkuch W
Department of Medical Microbiology and Immunology, Ruhr-Universität Bochum, Germany.
Med Microbiol Immunol. 1993 May;182(2):63-76. doi: 10.1007/BF00189374.
Helicobacter pylori, the causative agent of type-B gastritis and duodenal ulcer in man is described as a bacterium able to stimulate the human immune system. This study demonstrates that H. pylori besides this property possesses an immune suppressive activity. The in vitro proliferation of human peripheral blood mononuclear cells to purified protein derivative of tuberculin (PPD), phytohemagglutinin, and concanavalin A was reduced in a dose-dependent manner by bacteria which had been inactivated by incubation at 56 degrees C as well as by a soluble cytoplasmic fraction of H. pylori. The immune suppressive effect on the mitogen-induced proliferation could be increased by preincubation of the mononuclear cells with H. pylori. The observed effect does not seem to be a specific phenomenon depending on prior exposure of the blood donors to H. pylori, since suppression occurred with mononuclear cells of H. pylori-infected patients as well as of antibody-negative healthy control individuals. The suppressive activity was non-dialyzable, heat-labile (100 degrees C, 30 min) and sensitive to trypsin. Furthermore, the treatment at 100 degrees C caused an increase in the capability of H. pylori to induce lymphoproliferation. This fact indicates that the suppressive factor is also effective on H. pylori antigens. While exogenous interleukin-2, could to a certain extent, restore the responsiveness of the lymphocytes after PPD-stimulation in the presence of H. pylori, the addition of interleukin-1 had no effect on the suppressed lymphoproliferation. Cell-separation and cell-mixing experiments indicated that an influence on monocytes rather than on T cells is the major cause of the observed suppressive effect. Although the immunological mechanisms involved in H. pylori-associated gastritis are not clearly defined, it is reasonable to presume that suppression of host defense mechanisms may contribute to the pathogenesis of this disease.
幽门螺杆菌是人类B型胃炎和十二指肠溃疡的病原体,被描述为一种能够刺激人体免疫系统的细菌。本研究表明,幽门螺杆菌除了具有这一特性外,还具有免疫抑制活性。人外周血单核细胞对结核菌素纯蛋白衍生物(PPD)、植物血凝素和刀豆球蛋白A的体外增殖,在56℃孵育灭活的细菌以及幽门螺杆菌的可溶性细胞质部分作用下,呈剂量依赖性降低。单核细胞与幽门螺杆菌预孵育可增强对丝裂原诱导增殖的免疫抑制作用。观察到的效应似乎不是一种取决于献血者先前是否接触过幽门螺杆菌的特异性现象,因为幽门螺杆菌感染患者以及抗体阴性的健康对照个体的单核细胞都出现了抑制作用。抑制活性不可透析、对热不稳定(100℃,30分钟)且对胰蛋白酶敏感。此外,100℃处理使幽门螺杆菌诱导淋巴细胞增殖的能力增强。这一事实表明,抑制因子对幽门螺杆菌抗原也有效。虽然外源性白细胞介素-2在一定程度上可以恢复幽门螺杆菌存在时PPD刺激后淋巴细胞的反应性,但添加白细胞介素-1对受抑制的淋巴细胞增殖没有影响。细胞分离和细胞混合实验表明,对单核细胞而非T细胞的影响是观察到的抑制作用的主要原因。虽然幽门螺杆菌相关性胃炎所涉及的免疫机制尚未明确界定,但合理推测宿主防御机制的抑制可能有助于该疾病的发病机制。